Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01401374
Other study ID # 10-148/10-149x
Secondary ID
Status Completed
Phase N/A
First received July 21, 2011
Last updated April 7, 2017
Start date March 2011
Est. completion date March 2016

Study information

Verified date April 2017
Source St. Luke's-Roosevelt Hospital Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study is an on-line survey posted on survey monkey that addresses some demographic and environmental issues that could potentially relate to vitiligo vulgaris onset or disease exacerbation.


Description:

The survey is designed to look at some issues that are pertinent to individuals with vitiligo, including access to care, severity of disease, under-reported disease activity, causative and exacerbating factors and co-morbid illnesses.


Recruitment information / eligibility

Status Completed
Enrollment 3258
Est. completion date March 2016
Est. primary completion date March 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Ability to complete survey

Exclusion Criteria:

- Inability to complete survey

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States St. Luke's-Roosevelt Hospital Center New york New York

Sponsors (1)

Lead Sponsor Collaborator
St. Luke's-Roosevelt Hospital Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation of Disease State in Vitiligo with Clinical and Psychological Measures Self-reported retrospective single survey
See also
  Status Clinical Trial Phase
Completed NCT00907062 - Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents Phase 1
Completed NCT00372307 - Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris Phase 2
Not yet recruiting NCT03234673 - The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo Phase 1
Completed NCT01206374 - Questionnaire and Laboratory Data on Vitiligo Vulgaris N/A